Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Rosemont Partners buys into frontier investment boutique Silk Invest

Tuesday, July 09, 2013
Opalesque Industry Update - Silk Invest and Rosemont announce that Rosemont has made an equity investment in Silk Invest. The investment proceeds will enable the company to continue the expansion of its leadership position within the frontier markets as the firm opens new offices and launches new products into North America and other markets outside of its original European base.

Silk Invest will remain fully independent and majority owned by its management team and partners. Rosemont, a private equity boutique focused exclusively on making investments in asset management companies, will own a minority stake.

Silk Invest has three independent investment teams for public markets equities, fixed income and private equity. It manages approximately $200 million in four different frontier equities strategies; a frontier fixed income fund and an African Food & beverages private equity fund. The primary investment focus is on in Africa, the Middle East and Frontier Asia with an emphasis on having local presence in the target regions. Silk Invest has pioneered investment strategies that capture consumer-driven trends in these markets and was also the first firm to launch a dedicated frontier fixed income fund in Europe.

Silk Invest was founded in 2008 in London by Zin Bekkali and a veteran team of investment professionals with proven expertise in investing in frontier and emerging markets. Seasoned asset managers Daniel Broby and Dr. Waseem Khan lead the company’s public markets and private equity teams. The team’s investment process incorporates seasoned institutional managers with local market expertise, representing 14 frontier countries, 18 languages and operating from offices in London, South Africa, Egypt, Morocco, UAE, Kenya and an upcoming local presence in Nigeria.

Zin Bekkali, Silk Invest’s CEO and Group CIO, commented on the transaction:

“Since launching the Company in 2008, our team, the majority who are from frontier markets, has established Silk Invest as an institutional specialist in frontier markets with track records of competitive performance and lower volatility. We aligned our investment processes with our positive macro convictions and we have pioneered consumer focused investing in these markets. We are excited by the opportunity to grow our company and enhance our client offerings as a partner with Rosemont. It was important for us to find a capital partner that would reinforce our independent boutique model and entrepreneurial culture of employee ownership.”

David Silvera, Managing Director of Rosemont, noted:

“We are excited to have the opportunity to work with the accomplished and diverse group of professionals at Silk Invest. We have come to know and respect the investment process and discipline of the team and we look forward to working with them as they continue to grow the company and serve their clients’ needs with a compelling and differentiable suite of frontier investment capabilities”.

Press release

www.silkinvest.com

www.rosemontpartnersllc.com

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its